A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

de Vries A. C. Q.; Thio H. B.; de Kort W. J. A.; Opmeer B. C.; van der Stok H. M.; de Jong E. M. G. J.; Horvath B.; Busschbach J. J. V.; Nijsten T. E. C.; Spuls Ph. I.

首页> 外文期刊>British Journal of Dermatology >A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

【24h】

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

机译：比较inciximab和依赖啶患者中度至重度慢性噬斑型牛皮癣患者的前瞻性随机对照试验：牛皮癣inciximab与依赖替辛比较评价（件）研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background There are currently no independent data available comparing infliximab and etanercept for the treatment of psoriasis.

机译：背景技术目前没有任何独立的数据，比较英夫利昔单抗和依赖伊斯坦普治疗牛皮癣。

著录项

来源
《British Journal of Dermatology》 |2017年第3期|共10页
作者
de Vries A. C. Q.; Thio H. B.; de Kort W. J. A.; Opmeer B. C.; van der Stok H. M.; de Jong E. M. G. J.; Horvath B.; Busschbach J. J. V.; Nijsten T. E. C.; Spuls Ph. I.;
展开▼
作者单位

Acad Med Ctr Dept Dermatol Meibergdreef 9 NL-1105 AZ Amsterdam Netherlands;

Erasmus MC Dept Dermatol NL-3015 CA Rotterdam Netherlands;

Amphia Hosp Dept Dermatol Molengracht 21 NL-4818 CK Breda Netherlands;

Acad Med Ctr Clin Res Unit Meibergdreef 9 NL-1105 AZ Amsterdam Netherlands;

Acad Med Ctr Dept Dermatol Meibergdreef 9 NL-1105 AZ Amsterdam Netherlands;

Radboud Univ Nijmegen Med Ctr Dept Dermatol Rene Descartesdreef 1 NL-6525 GL Nijmegen;

Univ Groningen Univ Med Ctr Groningen Dept Dermatol Hanzepl 1 NL-9713 GZ Groningen Netherlands;

Erasmus MC Med Psychol &

Psychotherapy Sect NL-3015 CA Rotterdam Netherlands;

Erasmus MC Dept Dermatol NL-3015 CA Rotterdam Netherlands;

Acad Med Ctr Dept Dermatol Meibergdreef 9 NL-1105 AZ Amsterdam Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献

1. A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study [J] . de Vries A. C. Q., Thio H. B., de Kort W. J. A., British Journal of Dermatology . 2017,第3期

机译：比较inciximab和依赖啶患者中度至重度慢性噬斑型牛皮癣患者的前瞻性随机对照试验：牛皮癣inciximab与依赖替辛比较评价（件）研究
2. Onychomycosis in patients of nail psoriasis on biologic therapy: A randomized, prospective open label study comparing Etanercept, Infliximab and Adalimumab [J] . Al-MutairiN., NourT., Al-RqobahD. Expert opinion on biological therapy . 2013,第5期

机译：生物疗法治疗指甲牛皮癣患者的甲癣：一项比较Etanercept，Infliximab和Adalimumab的随机，前瞻性开放标签研究
3. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1). [J] . Barker J, Hoffmann M, Wozel G, British Journal of Dermatology . 2011,第5期

机译：英夫利昔单抗与氨甲蝶呤在中度至重度斑块状牛皮癣患者中的疗效和安全性：一项开放标签，主动控制，随机试验（RESTORE1）的结果。
4. Cluster Randomised Controlled Trial of a Mobile Monitoring and Feedback Tool Embedded in a Counselling Protocol to Stimulate Physical Activity in Chronically Ill Patients Study protocol of the It's LiFe! RCT [C] . Sanne van der Weegen, Huibert Tange, Trudy van der Weijden, International Conference on eHealth, Telemedicine, and Social Medicine . 2015

机译：集群随机对照试验的移动监测和反馈工具嵌入辅导议定书中，以刺激其生命的慢性病患者的体育活动！ RCT.
5. A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating the Effect of Infliximab on General Cognition in a Population of Depressed Individuals with Bipolar Disorder Type I/II [D] . Pan, Zihang. 2018

机译：一项随机，双盲，安慰剂对照的临床试验，评估英夫利昔单抗对I / II型双相情感障碍抑郁症患者总体认知的影响
6. A Randomized blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE) [O] . KA Papp, K Barber, R Bissonnette, -1

机译：对中度至重度斑块状牛皮癣（REFINE）患者进行每周一次的随机盲法评估者研究评估依那西普50 mg的有效性和安全性以及每周两次按需使用的局部用药依那西普50 mg的疗效和安全性
7. The EGALITY study:A confirmatory, randomised, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, versus the originator product in patients with moderate to severe chronic plaque-type psoriasis [O] . Griffiths, C E M, Thaçi, D, Gerdes, S, 2016

机译：EGaLITY研究：一项验证性，随机，双盲研究，比较Gp2015（一种拟生的依那西普生物仿制药）与中度至重度慢性斑块型银屑病患者的鼻祖产品的疗效，安全性和免疫原性

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

摘要

著录项

相似文献

相关主题

期刊订阅